197 related articles for article (PubMed ID: 36112207)
1. Advances in the differential diagnosis of transient hyperthyroidism in pregnancy and Graves' disease.
Guo N; Xue M; Liang Z
Arch Gynecol Obstet; 2023 Aug; 308(2):403-411. PubMed ID: 36112207
[TBL] [Abstract][Full Text] [Related]
2. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
Tagami T; Hagiwara H; Kimura T; Usui T; Shimatsu A; Naruse M
Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013
[TBL] [Abstract][Full Text] [Related]
3. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy.
Hidaka Y; Tamaki H; Iwatani Y; Tada H; Mitsuda N; Amino N
Clin Endocrinol (Oxf); 1994 Jul; 41(1):15-20. PubMed ID: 7914152
[TBL] [Abstract][Full Text] [Related]
4. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
Yoshihara A; Noh JY; Mukasa K; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Watanabe N; Suzuki N; Kameda T; Sugino K; Ito K
Endocr J; 2015; 62(6):557-60. PubMed ID: 25819223
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
6. Pitfalls in the assessment of gestational transient thyrotoxicosis.
Iijima S
Gynecol Endocrinol; 2020 Aug; 36(8):662-667. PubMed ID: 32301638
[TBL] [Abstract][Full Text] [Related]
7. Partial prediction of postpartum Graves' thyrotoxicosis by sensitive bioassay for thyroid-stimulating antibody measured in early pregnancy.
Ide A; Amino N; Nishihara E; Kudo T; Ito M; Kimura Y; Tatsumi N; Yamazaki M; Miyauchi A
Endocr J; 2016 Oct; 63(10):929-932. PubMed ID: 27432817
[TBL] [Abstract][Full Text] [Related]
8. Gestational and Postpartum Complications in Patients with First Trimester Thyrotoxicosis: A Prospective Multicenter Cohort Study from Northeast China.
Xu Y; Li C; Wang W; Yu X; Liu A; Shi Y; Xie X; Li J; Li Y; Shan Z; Teng W; Li Y
Thyroid; 2023 Jun; 33(6):762-770. PubMed ID: 37051708
[No Abstract] [Full Text] [Related]
9. Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study.
Zuhur SS; Ozel A; Velet S; Buğdacı MS; Cil E; Altuntas Y
Clinics (Sao Paulo); 2012; 67(2):125-9. PubMed ID: 22358236
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
Amino N; Yabu Y; Miyai K; Fujie T; Azukizawa M; Onishi T; Kumahara Y
Lancet; 1978 Aug; 2(8085):344-6. PubMed ID: 79711
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism in pregnancy.
Mestman JH
Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):394-401. PubMed ID: 22922367
[TBL] [Abstract][Full Text] [Related]
12. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
13. [Laboratory diagnosis before onset and prediction of Graves' disease].
Hidaka Y; Tada H; Amino N
Rinsho Byori; 1997 Sep; 45(9):825-30. PubMed ID: 9311254
[TBL] [Abstract][Full Text] [Related]
14. Significance of low thyroid-stimulating hormone in pregnancy.
Lazarus JH; Kaklamanou M
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):389-92. PubMed ID: 17940469
[TBL] [Abstract][Full Text] [Related]
15. Hyperthyroidism.
De Leo S; Lee SY; Braverman LE
Lancet; 2016 Aug; 388(10047):906-918. PubMed ID: 27038492
[TBL] [Abstract][Full Text] [Related]
16. Atypical Clinical Courses of Graves' Disease Confound Differential Diagnosis of Hyperthyroidism.
Yamaguchi Y; Okajima F; Sugihara H; Iwabu M; Emoto N
J Nippon Med Sch; 2024 Mar; 91(1):48-58. PubMed ID: 38072422
[TBL] [Abstract][Full Text] [Related]
17. Management of thyrotoxicosis and pregnancy: Review of the current literature and an update of the care pathway.
Caron P
Ann Endocrinol (Paris); 2022 Aug; 83(4):226-231. PubMed ID: 35143751
[TBL] [Abstract][Full Text] [Related]
18. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
19. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
Bahn Chair RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
Thyroid; 2011 Jun; 21(6):593-646. PubMed ID: 21510801
[TBL] [Abstract][Full Text] [Related]
20. Therapy insight: management of Graves' disease during pregnancy.
Chan GW; Mandel SJ
Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):470-8. PubMed ID: 17515891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
